BackAcura Pharmaceuticals Overview

Acura Pharmaceuticals Total Liabilities

Track Acura Pharmaceuticals's total liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$0.00

Peer trimmed avg / median

Loading

Acura Pharmaceuticals Total Liabilities History

Loading

Acura Pharmaceuticals vs. peers: Total Liabilities Comparison

Loading

Acura Pharmaceuticals Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Acura Pharmaceuticals (ACUR) FAQ

Acura Pharmaceuticals posts a total liabilities of $0 as of September 2023. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Acura Pharmaceuticals's total liabilities was $0. The latest reading is $0 (period ending September 2023). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of Acura Pharmaceuticals's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ACUR's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Acura Pharmaceuticals's other metric pages and overview cover the third.